CYTOTHERAPY Q2区

期刊简介

The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.

该杂志为读者带来快速发展的人体细胞治疗领域的最新进展。这包括癌症、免疫紊乱、遗传性疾病、组织修复和再生医学的细胞疗法。该杂志涵盖了各种细胞类型的科学、转化开发和治疗，包括造血干细胞、免疫细胞（树突细胞、NK 细胞、T 细胞、抗原呈递细胞）间充质基质细胞、脂肪细胞、神经、肌肉、血管和内皮细胞和诱导多能干细胞。我们也欢迎关于外泌体等亚细胞衍生物的手稿。特别关注将细胞疗法带入临床的转化研究。 Cytotherapy 出版原创论文、评论、立场文件社论、评论和致编辑的信件。我们欢迎“Protocols in Cytotherapy”为读者带来临床使用的生产特定细胞类型的标准操作程序。

《CYTOTHERAPY》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： DERMATOLOGISCHE WOCHENSCHRIFT
• 下一篇：Cutaneous and Ocular Toxicology